Philippines' Booming IVD Market: A New Hub for Asia-Pacific Medical Collaboration

Driven by rising healthcare demand and technological advancements, the in-vitro diagnostics (IVD) market in the Philippines has experienced rapid growth in recent years. This trend has captured the attention of both domestic and international companies.

This December, SERVE DIAGNOSTICA INC, a leading Philippine IVD distributor, will participate in the Taiwan Healthcare+ Expo at the Taipei Nangang Exhibition Center. The company aims to explore partnerships and expand its global footprint through this premier event.

Rising Demand: Policies and Trends Shaping the Philippine IVD Market

The Philippine government’s push for universal healthcare has significantly improved the country’s medical infrastructure and service quality. This development has directly fueled the demand for medical devices across the nation.

Meanwhile, an aging population and increasing cases of chronic diseases have intensified the need for efficient diagnostic tools. Advanced IVD technologies, such as molecular diagnostics and point-of-care testing (POCT), are emerging as essential solutions in meeting these demands.

In the post-pandemic era, IVD adoption has further accelerated, particularly in public health management and rapid screening. According to market research, the global IVD market is expected to grow at a compound annual growth rate (CAGR) of 6.7% through 2034, indicating substantial opportunities for both local and international companies.

Limited Domestic Capacity and High Reliance on Imports

Despite growing demand, the Philippines' domestic IVD production remains limited, with the market heavily reliant on imported products to fulfill its needs.

A report by Taiwan Trade Network in 2023 highlighted that locally produced medical devices account for less than 10% of the country's total demand. This dependency positions the Philippines as an attractive gateway for international companies to enter the Asia-Pacific market, offering importers considerable growth opportunities.

SERVE DIAGNOSTICA INC: A Strategic Step into Global Collaboration

Founded in 2015, **SERVE DIAGNOSTICA INC** has established itself as a leader in the Philippine IVD market. The company has partnered with over 300 local healthcare institutions and represents more than 15 international brands, focusing on providing high-quality diagnostic products that enhance the capabilities of local medical systems.

This December, the company will attend the Taiwan Healthcare+ Expo to explore new business opportunities. Key objectives include finding partners for in-vitro diagnostic devices, precision diagnostic equipment, and medical software, while also exploring broader international collaborations.

Taiwan Healthcare+ Expo: A Platform for Global Integration

As the largest AI-powered healthcare event in the Asia-Pacific region, the Taiwan Healthcare+ Expo offers an unparalleled platform for cross-industry collaboration. It brings together top-tier organizations and resources across the healthcare value chain, making it an ideal venue for SERVE DIAGNOSTICA INC to showcase its offerings and connect with potential partners.

The company’s participation at the expo will not only diversify the IVD options available in Taiwan but also strengthen collaboration between the healthcare industries of Taiwan and the Philippines. With this growing synergy, both regions stand to benefit from enhanced technological integration and accelerated commercial development.

● Also Want to Explore More Business Opportunities?
【Register for the 2024 Heathcare+ Expo Now to find the best partners! ▸】